1.A Case of Imported Dengue Fever with Acute Hepatitis.
Sang Jun SUH ; Yeon Seok SEO ; Jae Hong AHN ; Eun Bum PARK ; Sun Jae LEE ; Jang Uk SOHN ; Soon Ho UM
The Korean Journal of Hepatology 2007;13(4):556-559
Dengue fever is an acute febrile disease caused by the dengue virus, which belongs to the flaviviridae family, and this virus is transmitted by the bite of the mosquito Aedes aegypti. It occurs in the tropical climates of the South Pacific, Southeast Asia, India, Africa and the subtropical zone of America. Imported cases of Dengue fever and Dengue hemorrhagic fever are rapidly increasing as many Koreans are now traveling abroad. Liver injury is usually detected by laboratory investigation according to a surveillance protocol. Although liver injury by dengue virus has been described in Asia and the Pacific islands, the pathogenic mechanisms are not yet fully clarified. It is usually expressed in a self-limiting pattern and the patient has a complete recovery. We report here on a case of a young woman who presented with general weakness, nausea and significant elevation of the aminotransferase levels, and she was diagnosed with dengue fever.
Acute Disease
;
Adult
;
Dengue Hemorrhagic Fever/complications/*diagnosis/virology
;
Dengue Virus/*isolation & purification
;
Female
;
Hepatitis, Viral, Human/*diagnosis/virology
;
Humans
2.Recent Etiology and Clinical Features of Acute Viral Hepatitis in a Single Center of Korea.
Hyung Min KANG ; Sook Hyang JEONG ; Jin Wook KIM ; Donhun LEE ; Chang Kyu CHOI ; Young Soo PARK ; Jin Hyuk HWANG ; Nayoung KIM ; Dong Ho LEE
The Korean Journal of Hepatology 2007;13(4):495-502
BACKGROUND AND AIMS: The etiology of acute viral hepatitis in Korea has been dynamically changing during the recent years. The aim of this study was to investigate the recent etiology and the clinical features of acute viral hepatitis in a single center of Korea. METHODS: We performed a retrospective analysis of a prospective cohort of 55 patients who were diagnosed with acute viral hepatitis A to E during the period from May 2005 to August 2006. In addition to the clinically acute manifestations, the confirmatory serological tests were performed for the diagnosis of acute hepatitis A, B, C and E. RESULTS: The proportion of patients with acute viral hepatitis A, B, C, E and others were 56.4% (n=31), 12.7% (n=7), 18.2% (n=10), 9.1% (n=5) and 3.6% (n=2), respectively. The mean age of the patients with acute hepatitis A, B, C and E were 29.1+/-4.38, 38.7+/-11.72, 45.3+/-17.62 and 32.4+/-6.58 years, respectively. There was no fatal case. All cases of acute hepatitis B and six out of ten cases of acute hepatitis C recovered spontaneously. Four out of the five patients with acute hepatitis E had no history of travel to endemic area. CONCLUSIONS: The most common etiology of acute viral hepatitis in Korea is hepatitis A virus, and hepatitis C and B virus were the next most common causes. The sporadic cases of acute hepatitis E were not rare, and coinfection of HAV and HEV was observed. A multicenter, prospective study is warranted in the future.
Acute Disease
;
Adult
;
Aged
;
Cohort Studies
;
Female
;
Hepatitis A/diagnosis/epidemiology/virology
;
Hepatitis B/diagnosis/epidemiology/virology
;
Hepatitis C/diagnosis/epidemiology/virology
;
Hepatitis D/diagnosis/epidemiology/etiology
;
Hepatitis E/diagnosis/epidemiology/virology
;
Hepatitis Viruses/isolation & purification
;
Hepatitis, Viral, Human/*diagnosis/epidemiology/*virology
;
Humans
;
Korea
;
Male
;
Middle Aged
;
Retrospective Studies
3.A Case of Cholestatic Hepatitis Induced by Epstein-Barr Virus Infection.
Min Jae PARK ; In Kwon CHUNG ; Young Dae PARK ; Yun Jin CHUNG ; Ho Chul LEE ; Han Jin CHO ; Eun Hee SEO ; Chang Min CHO ; Won Young TAK ; Sung Kook KIM ; Yong Whan CHOI ; Young Oh KWEON
The Korean Journal of Hepatology 2006;12(2):237-242
Acute viral hepatitis in human can be caused by a large number of viruses with a wide range of clinical manifestations and laboratory findings. EBV is a rare causative agent of an acute hepatitis, during the course of infectious mononucleosis. Hepatic manifestations of EBV are usually mild and resolve without serious complications. EBV is rather uncommonly confirmed as an etiologic agent in acute viral hepatitis of adults and it rarely causes cholestatic hepatitis. We report a case of EBV hepatitis with cholestatic feature that was verified through serum viral marker and liver biopsy.
Male
;
Humans
;
Hepatitis, Viral, Human/complications/diagnosis/*virology
;
Epstein-Barr Virus Infections/complications/*diagnosis
;
Cholestasis, Intrahepatic/diagnosis/*virology
;
Adult
;
Acute Disease
4.Study on etiology of clinically diagnosed non A-E hepatitis.
Zhongping HE ; Hui ZHUANG ; Shujing SONG ; Xueping WANG ; Rongbing WANG ; Zhuang LIU
Chinese Journal of Experimental and Clinical Virology 2002;16(1):7-10
BACKGROUNDTo study etiology of clinically diagnosed non A-E hepatitis.
METHODSHBV, TTV, human parvovirus B19, SENV DNA were detected by nested polymerase chain reactions (nPCR), while HGV, HCV RNA were tested by reverse transcription nested polymerase chain reactions (RT-nPCR).
RESULTSOf 60 patients with clinically diagnosed non A-E hepatitis, 30 (50.0%) were HBV DNA positive alone, 10 (16.7%) HBV and TTV DNA positive, 6 (10.0%) HBV and B19 DNA positive; 1 (1.7%) HBV, SENV DNA and HCV RNA positive, 1 (1.7%) HCV RNA positive alone, 1 (1.7%) HCV RNA and B19 DNA positive, 2 (3.3%) B19 DNA positive alone, 1 (1.7%) TTV DNA positive alone, and the remaining 8 (13.3%) negative for all viruses. All the 60 patients were HGV RNA negative. There were no differences in serum biochemical markers of hepatitis B patients with or without TTV or B19 virus infection.
CONCLUSIONSHBV is a major etiologic agent for the clinically diagnosed non A-E hepatitis. HGV, TTV, B19 and SEBV may not be associated with nonA-E hepatitis.
Adult ; Aged ; DNA, Viral ; blood ; Female ; Hepacivirus ; genetics ; isolation & purification ; Hepatitis B ; diagnosis ; Hepatitis B virus ; genetics ; isolation & purification ; Hepatitis, Viral, Human ; diagnosis ; virology ; Humans ; Male ; Middle Aged ; RNA, Viral ; blood ; Sequence Analysis, DNA
6.The use of flow cytometry in detecting CMV-PP65 antigenemia for the diagnosis of CMV hepatitis.
Hong-can ZHAO ; Guo-qian XIANG ; Hong-qiang SHEN
Chinese Journal of Hepatology 2006;14(4):310-311
Adolescent
;
Antigens, Viral
;
blood
;
Child
;
Child, Preschool
;
Cytomegalovirus
;
immunology
;
Cytomegalovirus Infections
;
diagnosis
;
Female
;
Flow Cytometry
;
Hepatitis, Viral, Human
;
diagnosis
;
virology
;
Humans
;
Infant
;
Male
;
Phosphoproteins
;
blood
;
Viral Matrix Proteins
;
blood
7.HBV DNA Levels, Aminotransferase and Histological Activity in Young Male Patients with HBeAg Positive Chronic Hepatitis B.
Seung Chul CHO ; Soong Hwan LEE ; Joon Jae SHINN ; Sung Hee HAN ; Byung Joo ROH ; Joo Hyun SOHN ; Dong Hoo LEE ; Choon Suhk KEE
The Korean Journal of Hepatology 2002;8(1):44-51
BACKGROUND/AIM: A significant correlation between HBV DNA and liver damage was found in precore mutant strains but there was no significant association between viral replication and liver damage in HBeAg positive patients. Laboratory tests are often requested to predict hepatitis activity (grade) and fibrosis (stage) in HBeAg positive chronic hepatitis B. We assessed ALT, AST, and HBV-branched DNA to find which is the best for predicting hepatitis activity and fibrosis. METHODS: Routine biochemical liver function tests and HBV DNA in sera were assessed in 119 young patients positive with HBsAg and HBeAg. The mean age of patients was 21+/-2 years. All patients were male. By logistic regression analysis the relationships between laboratory data, hepatitis activity, fibrosis, or risk of chronic active hepatitis were analyzed. RESULTS: There was a significant correlation between aminotransferase (AST, ALT) and hepatitis activity/ fibrosis. A significant inverse relationship between the HBV bDNA and hepatitis activity was demonstrated (Pearson's correlation coefficient: lobular activity,-0.305; porto-periportal activity, -0.410). But HBV bDNA was not correlated with severity of fibrosis. AST and HBV bDNA was the important test for predicting the more severe hepatitis activity (lobular activity and porto-periportal activity: score> or =3, respectively) CONCLUSION: The higher AST, but the lower HBV bDNA, in sera shows the more severe hepatitis activity. AST and HBV bDNA could be helpful for assessing the hepatitis activity in young male patients with HBeAg positive chronic hepatitis B if proper reference values are used.
Adult
;
Alanine Transaminase/blood
;
Aspartate Aminotransferases/blood
;
DNA, Viral/*analysis
;
English Abstract
;
Enzyme Tests
;
Hepatitis B Virus/genetics/*isolation & purification
;
Hepatitis B e Antigens/*blood
;
Hepatitis B, Chronic/diagnosis/*pathology/virology
;
Human
;
Liver/pathology
;
Male
8.Changes in Liver Stiffness after Acute or Chronic Liver Injury due to Viral Hepatitis - Does Fibrosis Exist after Recovery from Acute Viral Hepatitis?.
Jeong Han KIM ; Hyung Joon YIM ; Seung Young KIM ; Jae Hong AHN ; Young Kul JUNG ; Moon Kyung JOO ; Su Hyun KIM ; Ji Hoon KIM ; Yeon Seok SEO ; Jong Eun YEON ; Hong Sik LEE ; Soon Ho UM ; Sang Woo LEE ; Kwan Soo BYUN ; Jae Hyun CHOI ; Ho Sang RYU
The Korean Journal of Gastroenterology 2009;54(3):155-161
BACKGROUND/AIMS: Liver stiffness (LS) measurement by transient elastography can estimate the degrees of liver fibrosis in patients with chronic liver disease. However, longitudinal data of LS after recovery of acute viral hepatitis are still lacking. In the present study, we aimed to evaluate among LS of patients at various stages of viral hepatitis and normal control. METHODS: Patients who had admitted at Korea University Ansan Hospital between January 2006 and January 2007 due to acute viral hepatitis and recovered were recruited (group A, n=22). We compared the liver biochmistry and LS of group A with those of healthy control group (group B, n=23), current acute viral hepatitis group (group C, n=49), and chronic viral hepatitis group (group D, n=66). RESULTS: Mean ALT, total bilirubin, and LS level of group A were not different from group B (p=0.318, p=0.116, p=0.125, respectively). However, group A had lower ALT, total bilirubin, and LS values compared to group C (all p<0.001), and lower ALT and LS values compared to group D (p=0.007, p<0.001). The mean total bilirubin was not significantly different from group D (p=0.117). CONCLUSIONS: Our data suggest that liver fibrosis is a long-term sequela of chronic hepatitis, and not developed in patients who recovered from acute viral hepatitis.
Acute Disease
;
Adolescent
;
Adult
;
Aged
;
Alanine Transaminase/blood
;
Bilirubin/analysis
;
Carrier State
;
Chronic Disease
;
Elasticity
;
Elasticity Imaging Techniques
;
Female
;
Hepatitis, Viral, Human/*complications/diagnosis
;
Humans
;
Liver/enzymology/*ultrasonography
;
Liver Cirrhosis/*ultrasonography/*virology
;
Male
;
Middle Aged
9.Parvovirus B19-induced Pure Red Cell Aplasia in a Liver Transplant Recipient.
Eun Young LEE ; Yonggeun CHO ; Sang Guk LEE ; Jaewoo SONG
The Korean Journal of Laboratory Medicine 2010;30(6):591-594
Parvovirus B19 infection is known to cause chronic anemia in immunocompromised hosts, including organ transplant recipients. We report the first case of liver transplant recipient with parvovirus B19-induced pure red cell aplasia in Korea. A 57-yr-old female patient with hepatocellular carcinoma due to hepatitis C virus received a liver transplantation. Two months later, anemia developed and she received periodic red blood cell transfusions. However, chronic anemia persisted and bone marrow examination was performed 8 months after transplantation. Bone marrow aspiration smears showed markedly reduced erythroid precursors with atypical giant pronormoblasts and nuclear remnants with viral inclusions, and characteristic lantern cells were observed in biopsy sections. In addition, parvovirus B19 DNA PCR was positive. She was diagnosed as parvovirus B19-induced pure red cell aplasia and her anemia was improved following intravenous immunoglobulin therapy.
Blood Transfusion
;
Bone Marrow/pathology
;
Carcinoma, Hepatocellular/etiology/therapy
;
DNA, Viral/analysis
;
Female
;
Hepatitis C/complications/diagnosis
;
Humans
;
Immunocompromised Host
;
Immunoglobulins/therapeutic use
;
Liver Neoplasms/etiology/therapy
;
Liver Transplantation
;
Middle Aged
;
Parvoviridae Infections/complications/*diagnosis
;
*Parvovirus B19, Human/genetics
;
Red-Cell Aplasia, Pure/*diagnosis/therapy/virology